IX

ORIX
D

IX

Arincen57/100B
32.600
USD
-1.56
(-4.57%)
Market Open
Last updated: · Delayed 15 min

ORIX return on equity (ROE)

ORIX's return on equity is 12.72%: net income of 647.78B JPY over the last twelve months on shareholders' equity of 5.09T JPY.

Today
12.72%
Average, 5 years
9.89%
Low, 5 years
7.88%
High, 5 years
20.29%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 647.78B ÷ 5.09T = 12.72%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives ORIX's return on equity?

Net margin
13.5%
profit on each dollar of sales
Asset turnover
0.20×
sales on each dollar of assets
Equity multiplier
4.02×
assets on each dollar of equity
Return on equity
10.6%
FY2026
  • FY202613.5% × 0.20 × 4.02 = 10.6%
  • FY202512.2% × 0.17 × 4.12 = 8.6%
  • FY202412.3% × 0.17 × 4.14 = 8.8%
  • FY202310.9% × 0.17 × 4.31 = 8.2%
  • FY202212.7% × 0.18 × 4.37 = 9.7%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today12.72%647.78B5.09T
FY202631 Mar 202610.18%458.33B4.50T
FY202531 Mar 20258.60%351.63B4.09T
FY202431 Mar 20248.78%346.13B3.94T
FY202331 Mar 20238.20%290.40B3.54T
FY202231 Mar 20229.57%312.14B3.26T
FY202131 Mar 20216.35%192.38B3.03T
FY202031 Mar 202010.11%302.70B2.99T
FY201931 Mar 201911.17%323.75B2.90T
FY201831 Mar 201811.67%313.14B2.68T
FY201731 Mar 201710.90%273.24B2.51T
FY201631 Mar 201611.26%260.17B2.31T
FY201531 Mar 201510.90%234.65B2.15T
FY201431 Mar 20149.36%179.50B1.92T
FY201331 Mar 20136.82%112.12B1.64T
FY201231 Mar 20126.02%84.06B1.40T
FY201131 Mar 20114.48%59.06B1.32T
FY201031 Mar 20102.22%28.87B1.30T
FY200931 Mar 20090.87%10.19B1.17T
FY200831 Mar 200811.64%146.86B1.26T
FY200731 Mar 200715.52%184.94B1.19T
FY200631 Mar 200615.67%149.76B955.51B
FY200531 Mar 200520.62%149.76B726.29B
FY200431 Mar 200415.00%84.51B563.49B
FY200331 Mar 20035.99%29.73B496.08B
FY200231 Mar 20028.01%40.14B501.20B
FY200131 Mar 20017.41%34.81B469.51B
FY200031 Mar 20007.20%29.66B412.05B
FY199931 Mar 19997.81%25.76B329.67B
FY199831 Mar 19987.56%23.73B313.82B

Figures in JPY. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Debt to equity,Current ratio,All ratios

Common questions about ORIX's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.